文献速递妇科

早期宫颈癌手术治疗患者术前宫颈锥切术的保护作用

Protective effect of pre-operative conization in patients undergoing surgical treatment for early-stage cervical cancer.
PubMed 文献 · Gynecol Oncol · 2022-05-23

该基于人群的队列研究分析了2010年1月至2015年12月期间接受根治性子宫切除术的FIGO IA1-IB1期宫颈癌患者,共235例纳入分析,中位随访5.4年。在FIGO IB1期肿瘤<2cm的患者中,术前宫颈锥切术与复发率降低相关(CO组3例复发,5.2%;NCO组25例复发,21.0%;p=0.007),DFS分别为94.8%和79.0%(p=0.008);多变量分析中锥切术为DFS有利因素(HR 0.27;95%CI 0.08-0.93,p=0.037),淋巴结受累为唯一不利因素(HR 4.38;95%CI 1.36-14.14,p=0.014)。

要点

  • 术前宫颈锥切术与早期宫颈癌根治性子宫切除术后DFS改善相关(HR 0.27;95%CI 0.08-0.93,p=0.037)。
  • FIGO IB1期肿瘤<2cm患者中,锥切组复发率5.2%(3例)低于无锥切组21.0%(25例),p=0.007。
  • 锥切组DFS 94.8%高于无锥切组79.0%,p=0.008;淋巴结受累为唯一不利因素(HR 4.38;95%CI 1.36-14.14,p=0.014)。

核心结论

  • 术前宫颈锥切术与早期宫颈癌DFS改善相关,且独立于手术方式。

研究设计与样本

  • 基于人群的队列研究,分析临床癌症登记数据,纳入2010年1月至2015年12月期间接受根治性子宫切除术的FIGO IA1-IB1期宫颈癌患者,共235例符合纳入标准,中位随访5.4年。

主要发现

  • 研究期间共观察28例(11.9%)复发,均发生于FIGO IB1期患者。
  • 在FIGO IB1期肿瘤<2cm患者中,术前锥切组(CO)复发3例(5.2%),无锥切组(NCO)复发25例(21.0%),p=0.007。
  • CO组DFS估计为94.8%,NCO组为79.0%,p=0.008。
  • 多变量分析中,锥切术为DFS有利因素(HR 0.27;95%CI 0.08-0.93,p=0.037),淋巴结受累为唯一不利因素(HR 4.38;95%CI 1.36-14.14,p=0.014)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to investigate the impact of pre-operative conization on disease-free survival (DFS) in early-stage cervical cancer. METHODS: In this population-based cohort study we analysed from clinical cancer registries to determine DFS of women with International Federation of Gynecology and Obstetrics (FIGO) stage IA1-IB1 cervical cancer with respect to conization preceding radical hysterectomy performed between January 2010 and December 2015. RESULTS: Out of 993 datasets available for the analysis, 235 patients met the inclusion criteria of the current study. The median follow-up was 5.4 years. During the study period, 28 (11.9%) recurrences were observed. All of these occurred in patients with FIGO stage IB1. For further evaluation, patients with FIGO IB1 tumors <2 cm were further analysed and divided into two groups, based on pre-operative conization. Pre-operative conization was associated with a reduced rate of recurrence (p = 0.007), with only three (5.2%) recurrences in this group (CO) compared to 25 recurrences (21.0%) in the group without conization (NCO) preceding radical hysterectomy. DFS was estimated at 79.0% and 94.8% in NCO and CO, respectively (p = 0.008). After adjustment for other prognostic covariates, conization remained a favourable prognostic factor for DFS (HR 0.27; 95% CI 0.08-0.93, p = 0.037). Lymph node involvement was the only unfavourable factor (HR 4.38; 95% CI 1.36-14.14, p = 0.014) in the multivariable analysis. CONCLUSIONS: Pre-operative conization is associated with improved DFS in early-stage cervical cancer independently of the surgical approach.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Gennari P, Tchaikovski S, Mészáros J, et al. Protective effect of pre-operative conization in patients undergoing surgical treatment for early-stage cervical cancer. Gynecol Oncol. 2022. PMID: 35618539. doi:10.1016/j.ygyno.2022.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。